5-chloro-N2-(2-isopropoxy-4-(piperidin-4-yl)-5-methylphenyl)-N4-(3-(isopropylsulfonyl)-1-methyl-1H-pyrazol-4-yl)pyrimidine-2,4-diamine

ID: ALA3604631

Chembl Id: CHEMBL3604631

PubChem CID: 118549960

Max Phase: Preclinical

Molecular Formula: C26H36ClN7O3S

Molecular Weight: 562.14

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1

Standard InChI:  InChI=1S/C26H36ClN7O3S/c1-15(2)37-23-12-19(18-7-9-28-10-8-18)17(5)11-21(23)31-26-29-13-20(27)24(32-26)30-22-14-34(6)33-25(22)38(35,36)16(3)4/h11-16,18,28H,7-10H2,1-6H3,(H2,29,30,31,32)

Standard InChI Key:  CIYFLYZJYHGCHM-UHFFFAOYSA-N

Associated Targets(Human)

ALK Tclin ALK tyrosine kinase receptor (7132 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H2228 (1030 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 562.14Molecular Weight (Monoisotopic): 561.2289AlogP: 5.10#Rotatable Bonds: 9
Polar Surface Area: 123.06Molecular Species: BASEHBA: 10HBD: 3
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.74CX Basic pKa: 10.34CX LogP: 4.35CX LogD: 2.40
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.33Np Likeness Score: -1.28

References

1. Zhang P, Dong J, Zhong B, Zhang D, Jin C, Meng X, Sun D, Xu X, Zhou Y, Liang Z, Ji M, Li H, Xu T, Song G, Zhang L, Chen G, Yuan H, Shih J, Zhang R, Hou G, Jin Y, Yang Q..  (2015)  Discovery of 2-arylamino-4-(1-methyl-3-isopropylsulfonyl-4-pyrazol-amino)pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors.,  25  (17): [PMID:26130408] [10.1016/j.bmcl.2015.06.021]
2. Zhang P, Dong J, Zhong B, Zhang D, Yuan H, Jin C, Xu X, Li H, Zhou Y, Liang Z, Ji M, Xu T, Song G, Zhang L, Chen G, Meng X, Sun D, Shih J, Zhang R, Hou G, Wang C, Jin Y, Yang Q..  (2016)  Design and synthesis of novel 3-sulfonylpyrazol-4-amino pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors.,  26  (8): [PMID:26979157] [10.1016/j.bmcl.2016.03.017]

Source